Status:
RECRUITING
Evaluation of Mood Disorders Under Biologics in Chronic Inflammatory Rheumatic Disease
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Rheumatic Diseases
Mood Disorders
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Chronic inflammatory rheumatic diseases (CIRD) affect many organ systems. Painful sensations within the joints spine, hand and foot deformities, low quality of life and psychosocial status in patients...
Eligibility Criteria
Inclusion
- Adult patients (≥18 ; ≤ 80)
- Patient with rheumatoid arthritis (RA) according to the ACR 2010 criteria, axial or peripheral spondyloarthritis (SpA) according to ASAS criteria, ankylosing spondylitis (AS) according to the New York criteria or psoriatic arthritis (PsA) according to CASPAR criteria
- Signature of informed consent
- Affiliation to a French social security or receiving such a scheme
Exclusion
- Patient having previously received anti-TNFα treatment
- Patient with previously diagnosed depressive or psychiatric pathology and / or receiving anti-depressant treatment
- Subjects with limited legal capacity.
- Subjects judged by the investigator to be unlikely to comply with study procedures
- Subjects with no social security coverage.
- Pregnant women.
- Subjects still in the exclusion period of another study, or according to the national registry of clinical trial participants.
Key Trial Info
Start Date :
May 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04817072
Start Date
May 19 2021
End Date
May 1 2026
Last Update
July 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Besançon, France, 25000